Equities

Sumitomo Pharma Co Ltd

Sumitomo Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)3.48
  • Today's Change0.02 / 0.58%
  • Shares traded370.00
  • 1 Year change+35.94%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:09 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue314,558555,544560,035
OPERATING EXPENSES
Cost of revenue total126,528178,494157,116
Selling, general and admin. expenses, total225,882283,474220,620
Depreciation/amortization31,83334,10431,742
Unusual expense(income)174,99722,837(255)
Other operating expenses, total2,003(18244)(4325)
Total operating expense669,417632,523499,801
Operating income(354859)(76979)60,234
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(323114)(47920)82,961
Provision for income taxes(8185)48,79442,361
Net income after taxes(314929)(96714)40,600
Minority interest(40)22,20215,813
Net income before extra. Items(314969)(74512)56,413
Total extraordinary items------
Net income(314969)(74512)56,413
Inc.avail. to common excl. extra. Items(314969)(74512)56,413
Inc.avail. to common incl. extra. Items(314969)(74512)56,413
EPS RECONCILIATION
Basic/primary weighted average shares397397397
Basic/primary eps excl. extra items(793)(188)142
Basic/primary eps incl. extra items(793)(188)142
Dilution adjustment------
Diluted weighted average shares397397397
Diluted eps excl. extra items(793)(188)142
Diluted eps incl. extra items(793)(188)142
COMMON STOCK DIVIDENDS
DPS - common stock primary issue02128
Gross dividend - common stock08,34311,124
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental3,8932,6402,970
SUPPLEMENTAL INCOME
Depreciation, supplemental9,64811,95911,451
Total special items174,99722,837(255)
NORMALISED INCOME
Normalized income before taxes(148117)(25083)82,706
Effect of special items on income taxes61,2497,993(130)
Income tax excluding impact of special items53,06456,78742,231
Normalized income after tax(201181)(81870)40,475
Normalized income avail. to common(201221)(59668)56,288
Basic normalized EPS(506)(150)142
Diluted normalized EPS(506)(150)142
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.